Spirax Group reported a 1.6% Global IP for the first nine months of the year, with full year forecasts revised down to 1.6%. Third quarter IP was lower due to weakness in key markets, but organic sales growth and adjusted operating profit margin for the ten months ended October 31 were ahead of the first half. The Group remains on track to deliver savings of approximately 35 million pounds from restructuring. Guidance for the full year remains unchanged, with expectations of organic revenue growth consistent with 2024 and mid-single digit organic growth in adjusted operating profit. Uncertainty around tariffs continues to impact global trade.

Read more at Nasdaq: Spirax Issues Trading Update; FY Guidance Remains Unchanged